BIOMAT Database Logo BIOMAT Database Logo

Osteomalacia in presence of "normal" serum 25-hydroxycholecalciferol concentration. 1981

K Kafetz, and H M Hodkinson

UI MeSH Term Description Entries
D010018 Osteomalacia Disorder caused by an interruption of the mineralization of organic bone matrix leading to bone softening, bone pain, and weakness. It is the adult form of rickets resulting from disruption of VITAMIN D; PHOSPHORUS; or CALCIUM homeostasis. Adult Rickets,Rickets, Adult
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D002112 Calcifediol The major circulating metabolite of VITAMIN D3. It is produced in the LIVER and is the best indicator of the body's vitamin D stores. It is effective in the treatment of RICKETS and OSTEOMALACIA, both in azotemic and non-azotemic patients. Calcifediol also has mineralizing properties. 25-Hydroxycholecalciferol,25-Hydroxyvitamin D 3,25-Hydroxycholecalciferol Monohydrate,25-Hydroxyvitamin D3,Calcidiol,Calcifediol Anhydrous,Calcifediol, (3 alpha,5Z,7E)-Isomer,Calcifediol, (3 beta,5E,7E)-Isomer,Calderol,Dedrogyl,Hidroferol,25 Hydroxycholecalciferol,25 Hydroxycholecalciferol Monohydrate,25 Hydroxyvitamin D 3,25 Hydroxyvitamin D3,Anhydrous, Calcifediol,Monohydrate, 25-Hydroxycholecalciferol
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006887 Hydroxycholecalciferols Hydroxy analogs of vitamin D 3; (CHOLECALCIFEROL); including CALCIFEDIOL; CALCITRIOL; and 24,25-DIHYDROXYVITAMIN D 3. Hydroxyvitamins D,Hydroxycholecalciferol
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

K Kafetz, and H M Hodkinson
Serum 25-hydroxycholecalciferol concentration in newly detected hypertension.
April 1995, American journal of hypertension,
K Kafetz, and H M Hodkinson
25-Hydroxycholecalciferol absorption in steatorrhoea and postgastrectomy osteomalacia.
May 1977, British medical journal,
K Kafetz, and H M Hodkinson
The interrelationships between serum 25-hydroxycholecalciferol, serum parathyroid hormone and bone changes in anticonvulsant osteomalacia.
March 1977, Acta endocrinologica,
K Kafetz, and H M Hodkinson
[Biological activity of 25-hydroxycholecalciferol in vitamin resitant osteomalacia].
January 1970, Calcified tissue research,
K Kafetz, and H M Hodkinson
Serum-25-hydroxycholecalciferol in hyperthyroidism.
April 1977, Lancet (London, England),
K Kafetz, and H M Hodkinson
Serum 25-hydroxycholecalciferol in uremia.
January 1974, Nephron,
K Kafetz, and H M Hodkinson
[Plasma concentration of 25-hydroxycholecalciferol in infants].
July 1984, Boletin medico del Hospital Infantil de Mexico,
K Kafetz, and H M Hodkinson
[Determination of 25-hydroxycholecalciferol in serum].
March 1984, Revista espanola de fisiologia,
K Kafetz, and H M Hodkinson
Serum 25-hydroxycholecalciferol in Greek uremics.
July 1980, Investigative urology,
K Kafetz, and H M Hodkinson
Interrelationships between serum 25-hydroxycholecalciferol, serum parathyroid hormone and morphometric bone changes in anticonvulsant osteomalacia. Therapeutic effect of vitamin D2.
May 1977, Calcified tissue research,
Copied contents to your clipboard!